Enzalutamide Improves Undetectable PSA Rates Alone and With

Enzalutamide alone and with leuprolide led to greater rates of undetectable PSA levels vs leuprolide alone in castration-sensitive prostate cancer.

Related Keywords

United States , American , , American Urological Association Annual Meeting , Sumitomo Pharma America Inc , Astellas Pharma Inc , Pfizer Inc , Dendreon Pharmaceuticals , Myovant Sciences Inc , Astrazeneca , Urological Association Annual , Johnson Innovative Medicine , Sumitomo Pharma America , Myovant Sciences , News , Prostate Cancer , Conference ,